Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026)
Revvity's (RVTY) quarterly Other Non-Current Liabilities came in at $771.4 million in Q3 2026, up 3557.46% on a YoY basis from $21.1 million in Q3 2025, and up 2984.08% quarter-over-quarter from $25.0 million in Q2 2026.
Analysis
Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Other Non-Current Liabilities for 17 consecutive years, with $771.4 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Other Non-Current Liabilities rose 3557.46% year-over-year to $771.4 million; the trailing twelve-month figure through Jul 2026 stood at $771.4 million (up 3557.46% YoY), and the FY2025 full-year result was $807.5 million, up 3611.95% from the prior year.
- Other Non-Current Liabilities grew to $771.4 million in Q3 2026 per RVTY's latest filing, from $25.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.2 billion in Q4 2022 and bottomed at $19.7 million in Q1 2025.
- Historically, Other Non-Current Liabilities has averaged $309.4 million across 5 years, with a median of $46.6 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 45.62% in 2024, then soared 3611.95% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $1.2 billion in 2022, then slumped by 96.75% to $40.0 million in 2023, then plunged by 45.62% to $21.8 million in 2024, then jumped by 3611.95% to $807.5 million in 2025, then fell by 4.47% to $771.4 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $771.4 million, $25.0 million, and $807.5 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 771.36 Mn |
| Apr 5, 2026 | 25.01 Mn |
| Dec 28, 2025 | 807.46 Mn |
| Sep 28, 2025 | 755.16 Mn |
| Jun 29, 2025 | 21.09 Mn |
| Mar 30, 2025 | 19.74 Mn |
| Dec 29, 2024 | 21.75 Mn |
| Sep 29, 2024 | 846.00 Mn |
| Jun 30, 2024 | 30.54 Mn |
| Mar 31, 2024 | 30.52 Mn |
| Dec 31, 2023 | 40.01 Mn |
| Oct 1, 2023 | 993.05 Mn |
| Jul 2, 2023 | 37.56 Mn |
| Apr 2, 2023 | 43.83 Mn |
| Jan 1, 2023 | 46.62 Mn |
| Oct 2, 2022 | 1.23 Bn |
| Jul 3, 2022 | 48.59 Mn |
| Apr 3, 2022 | 49.83 Mn |
| Jan 2, 2022 | 58.00 Mn |
| Oct 3, 2021 | 1.51 Bn |